*Corresponding author:
Hamid Moghaddasi,
Professor of Health Information Management and Medical Informatics,
Department of Health Information Technology & Management, School of
Paramedical Sciences, Shahid Beheshti University of Medical Sciences,
Tehran, Iran.
Email: moghaddasi@sbmu.ac.ir
- Abstract
Between one and two percent of the population of the developed countries
are currently treated with oral anticoagulation therapy. The transition of
all or part of the responsibility for therapy management to the patient
is an appropriate strategy to respond to the increasing demand for oral
anticoagulation therapy. The main objective of this original study was to
investigate the impact of using mobile applications on health outcomes
in patient self-management of oral anticoagulation therapy. An Android
mobile application called XrinA was developed to provide warfarin
patient self-management. The study was conducted following a BeforeAfter study design. In the “Before” and “After” periods, 21 patients were
first treated as usual and then by using the developed application. In the
“Before” period, the mean percentage of International Normalized Ratios
(INRs) within the therapeutic range and Time in Therapeutic Range (TTR)
of patients was 31.5% and 34.3%, respectively. In the “After” period, the
mean percentage of INRs within the therapeutic range and TTR of patients
was 41.4% and 50.1%. Overall, the use of mHealth applications improved
the Patient Self-Management of oral anticoagulation therapy in terms of
the percentage of INRs within the therapeutic range and TTR. - Keywords:
Vitamin K antagonists; oral anticoagulation therapy; self-management;
mobile health.
Citation:
Hamid Moghaddasi. The Impact of Mobile Health on Oral Anticoagula
tion Therapy: E-selfcare in Cardiotherpy. Journal of Clinical Cases 2024.
